Mr. Abhishek Jha|Pharmacology|Best Researcher Award
Mr. Abhishek Jha, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, India.
Abhishek Jha is a final-year doctoral candidate at the Indian Institute of Technology (BHU), Varanasi, specializing in Pharmaceutical Engineering and Technology. His research focuses on developing nanomedicine-based therapeutic strategies, particularly for breast and lung cancer treatments. Abhishek has hands-on experience with a range of sophisticated instruments, including HPLC, SEM, and fluorescence microscopy, and is proficient in various software used for data analysis and drug formulation. He has contributed to multiple high-impact publications in areas such as targeted drug delivery, nanofiber-based wound healing, and tuberculosis therapy. His projects involve innovative approaches, including redox-responsive nanocarriers and pulmonary nanocrystals, aimed at improving the efficacy and specificity of cancer treatments. With a passion for research and mentoring, Abhishek has guided several undergraduate and postgraduate students. His work, recognized in peer-reviewed journals, reflects his commitment to advancing pharmaceutical sciences, making him a strong contender for research excellence awards.
Profile
Education
Abhishek Jha is a dedicated scholar with a robust educational background in pharmaceutical sciences. He is currently pursuing a Ph.D. in Pharmaceutical Engineering and Technology at the prestigious Indian Institute of Technology (IIT-BHU), Varanasi. His doctoral research, initiated in July 2019, focuses on innovative strategies for nanomedicine-based treatments for breast cancer, with a particular emphasis on tumor-targeted drug delivery systems. Prior to this, Abhishek earned his Master of Pharmacy (M.Pharm) from the same institution in June 2019, specializing in Pharmaceutics. During his postgraduate studies, he achieved an impressive C.G.P.A. of 9.43, showcasing his academic excellence. His foundation in the field was laid during his Bachelor of Pharmacy (B.Pharm) studies at KIET School of Pharmacy, affiliated with AKTU, Ghaziabad, where he graduated with a strong 85.8% in 2017. Abhishek’s education reflects his deep commitment to pharmaceutical research and innovation, laying the groundwork for his promising career in academia and industry.
Professional Experience
Abhishek Jha is a Senior Research Fellow at the Indian Institute of Technology (BHU), Varanasi, where he has been working since July 2019. He is currently pursuing his doctoral degree under the supervision of Prof. Brahmeshwar Mishra, focusing on developing nanomedicine-based strategies for breast cancer therapy. His research includes creating redox-responsive, self-assembled systems for targeted drug delivery and localized breast cancer treatments using dissolving microneedles. Abhishek has extensive experience in the development of nanofibrous matrices for wound healing and tissue regeneration, and has mentored over 20 M. Tech and B. Tech students. Prior to his doctoral research, he worked as a Post-graduate Research Scholar at IIT (BHU) from January 2018 to June 2019, where he gained expertise in fabricating polymeric nanoparticles, micelles, liposomes, and hydrogels, and optimized various disease models for lung and breast cancer, diabetes, and infections in rats, applying QbD approaches for formulation optimization.
Research Interest
Abhishek Jha’s research interests lie at the intersection of pharmaceutical sciences and nanomedicine, focusing on innovative drug delivery systems for targeted cancer therapies. His work emphasizes the development of nanocarriers that enhance the selective accumulation of therapeutics in tumor sites, particularly in the treatment of breast and lung cancers. Jha is particularly skilled in designing redox-responsive self-assembled systems and microneedle technologies to facilitate localized drug delivery. Additionally, he investigates nanofibrous scaffolds with wound healing and anti-infective properties, aiming to improve patient outcomes in chronic diabetic wounds. His extensive experience in formulating various nanomedicines, including polymeric nanoparticles, liposomes, and hydrogels, showcases his commitment to advancing drug delivery approaches. Through his research, Jha aims to contribute significantly to the fields of pharmaceutics and biomedical engineering, ultimately improving therapeutic efficacy and patient care in complex disease management.
Research Skills
Abhishek Jha possesses a robust set of research skills that significantly contribute to his expertise in pharmaceutical engineering and technology. His hands-on experience with sophisticated instruments such as High-Performance Liquid Chromatography, Electron Microscopes, and Atomic Force Microscopes demonstrates his proficiency in advanced analytical techniques. Abhishek’s adeptness in interpreting various spectra for drug characterization, including Differential Scanning Calorimetry and Nuclear Magnetic Resonance spectroscopy, showcases his comprehensive understanding of pharmaceutical formulations. He has successfully developed nanomedicine-based strategies for cancer treatment, exhibiting strong problem-solving skills and innovative thinking. His involvement in mentoring over 20 M. Tech and B. Tech students highlights his leadership abilities and commitment to collaborative research. Additionally, Abhishek’s proficiency in software tools like JMP and Minitab enhances his capacity for data analysis and interpretation. Overall, his combination of technical expertise, mentoring experience, and analytical skills positions him as a valuable asset in the field of pharmaceutical research.
Award and Recognition
Abhishek Jha, a promising final-year doctoral candidate at the Indian Institute of Technology (BHU), Varanasi, has garnered notable recognition for his innovative research in pharmaceutical engineering and drug delivery systems. His work on developing nanomedicine-based strategies for breast cancer treatment has been published in prestigious journals, earning him accolades in the scientific community. Abhishek’s contributions include developing targeted therapies and biomaterials for chronic wound healing, showcasing his commitment to addressing complex medical challenges. He has actively engaged in mentoring over 20 undergraduate and graduate students, reflecting his dedication to fostering the next generation of researchers. His publications in high-impact journals, alongside collaborations with esteemed institutions, further underscore his reputation as a rising star in pharmaceutical sciences. Abhishek’s achievements have not only positioned him as a thought leader in his field but also earned him recognition within academic circles for his innovative approach to drug delivery and cancer therapy.
Conclusion
Abhishek Jha is a highly capable researcher with exceptional skills in nanomedicine and drug delivery systems. His academic excellence, technical proficiency, and extensive publication record position him as a strong contender for the Best Researcher Award. By broadening his research scope and further engaging with industry and public platforms, he could reach new heights in his career, making him a well-deserved candidate for recognition in his field.
Publication Top Notes
- Electrospun nanofiber-based drug delivery platform: advances in diabetic foot ulcer management
DR Madhukiran, A Jha, M Kumar, G Ajmal, GV Bonde, B Mishra
Expert Opinion on Drug Delivery 18 (1), 25-42, 2021. - Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy
M Kumar, A Jha, M Dr, B Mishra
Expert Opinion on Drug Delivery 17 (10), 1459-1472, 2020. - Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis
DM Pawde, MK Viswanadh, AK Mehata, R Sonkar, S Poddar, AS Burande, …
Saudi Pharmaceutical Journal 28 (12), 1616-1625, 2020. - DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer
A Jha, MK Viswanadh, AS Burande, AK Mehata, S Poddar, K Yadav, …
International Journal of Biological Macromolecules 150, 413-425, 2020. - Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics
R Sonkar, A Jha, MK Viswanadh, AS Burande, DM Pawde, KK Patel, …
Materials Science and Engineering: C 120, 111652, 2021. - Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy
MK Viswanadh, N Agrawal, S Azad, A Jha, S Poddar, SK Mahto, …
International Journal of Pharmaceutics 602, 120652, 2021. - Formulation and In Vivo Efficacy Study of Cetuximab Decorated Targeted Bioadhesive Nanomedicine for Non-Small-Cell Lung Cancer Therapy
MK Viswanadh, Vikas, A Jha, SK Reddy Adena, AK Mehata, V Priya, …
Nanomedicine 15 (24), 2345-2367, 2020. - Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation
A Gupta, S Shetty, S Mutalik, K Nandakumar, EM Mathew, A Jha, B Mishra, …
Heliyon 9 (10), 2023. - Nanocarriers for tuberculosis therapy: design of safe and effective drug delivery strategies to overcome the therapeutic challenges
K Sarkar, M Kumar, A Jha, K Bharti, M Das, B Mishra
Journal of Drug Delivery Science and Technology 67, 102850, 2022. - Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders
M Kumar, A Jha, K Bharti, G Parmar, B Mishra
Nanomedicine 17 (12), 913-934, 2022. - Myricetin encapsulated chitosan nanoformulation for management of type 2 diabetes: preparation, optimization, characterization and in vivo activity
M Upadhyay, RV Hosur, A Jha, K Bharti, PS Mali, AK Jha, B Mishra, …
Biomaterials Advances 153, 213542, 2023. - DNA-Based Nanostructured Platforms as Drug Delivery Systems
M Kumar, A Jha, B Mishra
Chem & Bio Engineering 1 (3), 179-198, 2024. - Enhanced in vitro therapeutic efficacy of triphenyltin (IV) loaded vitamin E TPGS against breast cancer therapy
M Singh, NK Rana, MS Muthu, A Jha, TSB Baul, B Koch
Materials Today Communications 31, 103256, 2022. - Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy
A Jha, M Kumar, K Bharti, M Manjit, B Mishra
Nanomedicine 19 (7), 633-651, 2024. - Fabrication of gelatin coated polycaprolactone nanofiber scaffolds co-loaded with luliconazole and naringenin for treatment of Candida infected diabetic wounds
M Manjit, K Kumar, M Kumar, A Jha, K Bharti, P Tiwari, R Tilak, V Singh, …
International Journal of Biological Macromolecules 261, 129621, 2024. - Formulation and characterization of polyvinyl alcohol/chitosan composite nanofiber co-loaded with silver nanoparticle & luliconazole encapsulated poly lactic-co-glycolic acid …
M Manjit, M Kumar, A Jha, K Bharti, K Kumar, P Tiwari, R Tilak, V Singh, …
International Journal of Biological Macromolecules 258, 128978, 2024. - Marine biopolymers for transdermal drug delivery
M Kumar, A Jha, B Mishra
Marine Biomaterials: Drug Delivery and Therapeutic Applications, 157-207, 2022. - Marine Biopolymer-Based Anticancer Drug Delivery Systems
A Jha, M Kumar, B Mishra
Marine Biomaterials: Drug Delivery and Therapeutic Applications, 351-401, 2022. - Metronidazole Loaded Polycaprolactone-Carbopol Blends Based Biodegradable Intrapocket Dental Film for Local Treatment of Periodontitis
N Dhedage, G Khan, G Ajmal, M Kumar, A Jha, B Mishra
Drug Delivery Letters 11 (1), 34-43, 2021. - Lipid-coated nanocrystals of paclitaxel as dry powder for inhalation: Characterization, in-vitro performance, and pharmacokinetic assessment
M Kumar, A Jha, K Bharti, M Manjit, P Kumbhar, V Dhapte-Pawar, …
Colloids and Surfaces B: Biointerfaces 237, 113865, 2021.